SUTIMLIMAB-JOME | B761164 | RECORDATI RARE DISEASES, INC.
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Feb. 4, 2034 | Active | Computed |
| 7-Year Orphan | Feb. 4, 2029 | Active | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 11020459(formulation) · relevance 50/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
4 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.